RetaSlim Retatrutide SQ 10/30/60 mg Vial, PeptoLabs

Our online store now offers a new product, Retatrutide PeptoLabs in a 60 mg dose. If you have been trying to lose weight for a long time, this may be an option to consider, particularly if diet and exercise have not produced the desired results. This product may be a deciding factor.

What is Retatrutide?

It is a product that may help address excess weight and metabolic disorders such as obesity and type 2 diabetes. The active substance affects receptors for the incretin hormones GLP-1, GIP and glucagon.

How it works:

• GLP-1 stimulates insulin production, reduces appetite and slows digestion.

• GIP supports pancreatic function and enhances the effect of GLP-1.

• Glucagon receptors regulate energy expenditure and stimulate fat burning.

Retatrutide has an advantage over products that affect only GLP-1, such as Semaglutide, or GLP-1 and GIP, such as Tirzepatide. By activating all three types of receptors, the product reduces appetite and provides a lasting feeling of satiety.

Additional effects:

• Normalisation of blood glucose levels.  

• Weight loss.

Clinical trials have shown that patients taking Retatrutide lose more than 24% of their body weight. The product is also well tolerated.

Retatrutide (Retatrutide SQ) promotes weight loss by affecting appetite and fat metabolism. In addition, because it affects three types of receptors, Retatrutide PeptoLabs is used in lower doses than Semaglutide and Tirzepatide. Achieving the effect requires three times less active substance, while the product acts 30% more strongly.

If Semaglutide or Tirzepatide did not help you, Retatrutide may be an effective alternative. The course should begin with the lowest dose, regardless of previous experience.

Like any product that affects incretin receptors, Retatrutide may cause side effects such as nausea, vomiting, diarrhoea or constipation. They usually occur at the start of treatment and pass over time. Retatrutide should only be taken under medical supervision.

Interested in Retatrutide PeptoLabs?

Novavroda delivers the product throughout Ukraine. We guarantee quality, compliance with expiry dates and correct storage. To ask whether Retatrutide PeptoLabs is suitable for you, contact our manager. (Retatrutide)

Use:

Consult a doctor before starting the course.

The average weight-loss course lasts 36-48 weeks.

Injections are administered subcutaneously once a week in the upper arm, thigh or abdomen.

Treatment begins with the lowest dosage, which is gradually increased if well tolerated, approximately as follows:

• Weeks 1-4, 2 mg;

• Weeks 5-8, 4 mg;

• Weeks 9-12, 6 mg;

• From week 13, 8-12 mg.

Exceeding the maximum dosage is not recommended.

Warning! The information on the website is for general information only, and the product is not a medicine. The manufacturer may change the appearance of the packaging without notice.

The product is intended for research purposes only, not for human use.  The information was collected through numerous studies and analyses conducted over many years and is not intended to diagnose, treat or prevent any disease.

*All results are individual and depend on your state of health